Komori
Management planning3353Medical Ikkou Group Co.,Ltd.Retail

Notice Regarding Compliance with the Continued Listing Criteria

As of the end of February 2026, the company complied with all of the Standard Market continued listing criteria, including the free-float ratio. The company is reporting its progress in achieving the plan as a result of initiatives undertaken under its compliance plan.

Worth reading
22Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Items stated in the management plan

Plan for Compliance with the Continued Listing Criteria for the New Market Segments / Revised Plan
Publication date 26 March 2026
Statements about the use of capital
Payout ratio / DOE policyThe company states that it revised its shareholder return policy, but the specific level and applicable period are not disclosedThe payout ratio is the proportion of profit paid out as dividends, while DOE is the ratio of dividends to net assets.
Key initiatives
01The company has sought to expand its investor base by presenting its medium- to long-term growth strategy and revising its shareholder return policy on the same day.
02The company has cancelled treasury shares.
03Off-auction distribution
Items stated in the management plan
ItemDetails
Plan namePlan for Compliance with the Continued Listing Criteria for the New Market Segments / Revised Plan
Payout ratio / DOE policyThe company states that it revised its shareholder return policy, but the specific level and applicable period are not disclosed
Key initiativesThe company has sought to expand its investor base by presenting its medium- to long-term growth strategy and revising its shareholder return policy on the same day., The company has cancelled treasury shares., Off-auction distribution
Publication date26 March 2026
Items this document does not state (21)
Plan periodProgress against the planSales TargetOperating profit targetOperating profit margin targetNet income targetROE targetROIC targetTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorSegment targetNon-financial targetsPlan assumptionsResults under the previous planReason for revision or withdrawalSize of the Target MarketRisks identifiedDate of board resolution

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Based on the plan submitted on 13 December 2021 and the revised plan dated 4 April 2025, the company worked to expand its investor base, revise its shareholder return policy, cancel treasury shares, and conduct an off-auction distribution of shares by business corporations and other entities. As a result, the free-float ratio met the applicable criterion.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Compliance with the Continued Listing Criteria | Medical Ikkou Group Co.,Ltd. (3353) timely disclosure | Komori